Promoting resistance by the emission of antibiotics from hospitals and households into effluent

Clinical Microbiology and Infection

Volumn 9, Issue 12, 2003, Pages 1203-1214

  Kummerer K ^a  

^a UNIVERSITY OF FREIBURG   (Germany)

Author keywords

Antibiotic; Effluent; Emission; Hospital; Resistance

Indexed keywords

AMIKACIN; AMOXICILLIN; AMPICILLIN; ANTIBIOTIC AGENT; AZITHROMYCIN; AZLOCILLIN; BACITRACIN; CEFACLOR; CEFADROXIL; CEFAZOLIN; CEFOTIAM; CEFTAZIDIME; CEFUROXIME; COLISTIN; DOXYCYCLINE; FLUCLOXACILLIN; GENTAMICIN; IMIPENEM; LEVOFLOXACIN; MEROPENEM; OFLOXACIN; PENICILLIN G; PENICILLIN V; PIPERACILLIN; RIFABUTIN; RIFAMPICIN; SURFACE WATER; TEICOPLANIN; TOBRAMYCIN; UNINDEXED DRUG;

ANTIBIOTIC RESISTANCE; ARTICLE; CALCULATION; CHEMICAL ANALYSIS; CONCENTRATION (PARAMETERS); DOMESTIC WASTE; DRUG USE; GERMANY; HOSPITAL WASTE; HUMAN; MATHEMATICAL COMPUTING; MEDICAL PRACTICE; MINIMUM INHIBITORY CONCENTRATION; PRESCRIPTION; PRIORITY JOURNAL; QUALITY CONTROL; RISK ASSESSMENT; SEWAGE EFFLUENT; STATISTICAL ANALYSIS; WASTE WATER MANAGEMENT;

BACTERIA (MICROORGANISMS);

EID: 0038621137     PISSN: 1198743X     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1469-0691.2003.00739.x     Document Type: Article

References (32)

1. Wise R, Hart T, Cars O et al. Antimicrobial resistance is a major threat to public health. BMJ 1998; 317: 609-10.
2. House of Lords (UK). House of Lords Select Committee on Science and Technology, 7th Report. London: Stationary Office, 1998.
3. McKellar QA. Antimicrobial resistance: a veterinary perspective. BMJ 1998; 317: 610-11.
4. Witte W. Medical consequences of antibiotic use in agriculture. Science 1998; 279: 996-7.
5. Hartmann A, Golet EM, Gartiser S, Alder AC, Koller T, Widmer R. Primary DNA damage but not mutagenicity correlates with ciprofloxacin concentrations in German hospital waste waters. Arch Environ Contam Toxicol 1999; 36: 115-19.
6. Hirsch R, Ternes T, Haberer K, Kratz KL. Occurrence of antibiotics in the aquatic environment. Sci Tot Environ 1999; 225: 109-18.
7. Zuccato E, Calamari D, Natangelo M, Fanelli R. Presence of therapeutic drugs in the environment. Lancet 2000; 335: 1789-90.
8. Golet EM, Alder AC, Hartmann A, Ternes TA, Giger W. Trace determination of fluoroquinolone antibacterial agents in urban wastewater by solid-phase extraction and liquid chromatography with fluorescence detection. Anal Chem 2001; 73: 3632-8.
9. Al-Ahmad A, Daschner FD, Kümmerer K. Biodegradability of cefotiam, ciprofloxacin, meropenem, penicillin G, and sulfamethoxazole and inhibition of waste water bacteria. Arch Environ Cont Toxicol 1999; 37: 158-63.
10. Kümmerer K, Al-Ahmad A, Mersch-Sundermann V. Biodegradability of some antibiotics, elimination of their genotoxicity and affection of waste water bacteria in a simple test. Chemosphere 2000; 40: 701-10.
11. Kümmerer K, ed. Pharmaceuticals in the environment. Sources, fate, effects and risks. Heidelberg: Springer, 2001.
12. Kümmerer K, Helmers E. Hospital effluents as a source of gadolinium in the aquatic environment. Environ Sci Technol 2000; 34: 573-7.
13. Schwabe U, Paffrath D, eds. Arzneiverordnungsreport 1998. Heidelberg: Springer Verlag, 1999.
14. Simon C, Stille W. Antibiotikatherapie in klinik und praxis, 8th edn. Stuttgart, New York: Schlattauer, 1993.
15. Gerding DN, Peterson LR, Hughes CE, Bamberger DM, Larson TA. Extravascular antimicrobial distribution and the respective blood concentrations in human. In: Lorian V, ed. Antibiotics in laboratory medicine, 3rd edn. Baltimore: Williams & Wilkins, 1991: 880-961.
16. European Union, Direction General III. Assessment of potential risks to the environment posed by medical products for human use (excluding products containing live genetically modified organisms). No. 5504/94 Draft 6, Version 4. Brussels: EU, 1995.
17. European Union. Technical Guidance Document in Support of Commission Directive 93/67/EEC on Risk Assessment for New Notified Substances. Commission regulation (EC) no. 1488/94 on risk assessment for existing substances, Part II. Brussels: EU, 1996.
18. Richardson ML, Bowron JM. The fate of pharmaceutical chemicals in the aquatic environment. J Pharm Pharmacol 1985; 37: 1-12.
19. European Federation of Animal Health (FEDESA). Antibiotics and animals. FEDESA/FEFANA Press release. Brussels: FEDESA, 2001.
20. Ingerslev F, Halling-Sørensen B. Biodegradability properties of sulphonamides; in activated sludge. Environ Toxicol Chem 2000; 19: 2467-73.
21. Kümmerer K, Al-Ahmad A, Wiethan J, Hertle W, Henninger A. Effects and fate of antibiotics in sewage treatment plants [abstract 3C/p003]. In: Abstracts of the 3rd SETAC World Congress, Brighton. Brussels: SETAC Europe, 2000: 134.
22. Christensen FM. Pharmaceuticals in the environment: a human risk. Regulatory. Toxicol Pharmacol 1998; 28: 212-21.
23. Wiethan J, Al-Ahmad A, Henninger A, Kümmerer K. Simulation des Selektionsdrucks der Antibiotika Ciprofloxacin und Ceftazidim in Oberflächengewässern mittels klassischer Methoden [Simulation of the selection pressure of the antibiotics. ciprofloxacin and ceftazidim in surface waters by means of classic methods.] Vom Wasser 2000; 95: 107-18.
24. Burhenne J, Ludwig M, Nikoloudis P, Spiteller M. Photolytic degradation of fluoroquinolone carboxylic acids in aqueous solution. Primary photo-products and half-lives. ESPR Environ Sci Pollut Res 1997; 4: 10-15.
25. Weerasinghe CA, Towner D. Aerobic biodegradation of virginiamycin in soil. Environ Toxicol Chem 1997; 16: 1873-6.
26. Marengo JR, Kok RA, Velagaleti R, Stamm JM. Aerobic degradation of 14C-sarafloxacin hydrochloride in soil. Environ Toxicol Chem 1997; 16: 462-71.
27. Hamscher G, Sczesny S, Abu-Qare A, Höpfer H, Nau H. Stoffe mit pharmakologischer Wirkung einschlieβlich hormonell aktiver Substanzen in der Umwelt: Nachweis von Tetracyclinen in güflegedüngten Böden. [Substances with pharmacological effects including hormonally active substances in the environment: identification of tetracyclines in soil fertilized with animal slurry.] Dtsche Tierärztliche Wochenschr 2000; 107: 332-4.
28. Gartiser S. Abschätzung des Beitrages kommunaler Kläranlagen an Schadstoffkonzentrationen in Oberflächengewässern. [Estimation of the contribution of municipal sewage treatment plants to hazardous concentrations in surface waters.] Z Umweltchem Ökotox 1999; 11: 157-62.
29. Gieringer JH, Wenz AF, Just HM, Daschner FD. Effects of 3-fluorouracil, mitoxantrone, methotrexate and vincristine on the antibacterial activity of ceftriaxone, ceftazidime, cefotiam, piperacillin and netilmicin. Chemotherapy 1986; 32: 418-24.
30. Kümmerer K, Al-Ahmad A. Biodegradability of the anti-tumour agents 5-fluorouracil, cytarabine and gemcitabine: impact of the chemical structure and synergistic toxicity with hospital effluents. Acta Hydrochim Hydrobiol 1997; 25: 166-72.
31. Aarestrup FM, Seyfarth AM, Embrog H-D, Pedersen K, Hendriksen RS, Bager F. Effect of abolishment of the use of antimicrobial agents for growth promotion on occurrence of antimicrobial resistance in fecal enterococci from food animals in Denmark. Antimicrob Agents Chemother 2001; 45: 2054-9.
32. Arnold M, Paffrath W. Krankenhausreport 95. Stuttgart: Gustav Fischer Verlag, 1995.